Injection Regimen Trial of PEG-rhG-CSF During Breast Cancer Chemotherapy
Status:
Recruiting
Trial end date:
2022-07-10
Target enrollment:
Participant gender:
Summary
The purpose of this study is to try to find a better injection regimen (including time and
dose) of PEG-rhG-CSF, which is supposed to better prevent bone marrow suppression and/or FN
in breast cancer patients who receive chemotherapy.
Phase:
Phase 2
Details
Lead Sponsor:
The First Affiliated Hospital with Nanjing Medical University